HPV immunisation programme: An update

Source: British Journal of School Nursing, 2015, 10 (5): 217-20.

Follow this link for abstract

Date of publication: June 2015

Publication Type: Journal Article

In a nutshell: Dorothy Lepkowska provides an update on the HPV immunisation programme’s progress, and looks at the uptake rates and the impact on health so far.

Length of publication: 3-page article

The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts

Source: PEDIATRICS, 2015, 135 (5), pp. 1131 – 1140

Follow this link for abstract

Date of publication: May 2015

Publication Type: Journal Article

In a nutshell: Background: Despite widespread promotion of quadrivalent human papillomavirus (qHPV) vaccination for young girls, there is limited information on the vaccine’s real-world effectiveness and none on the effectiveness of qHPV vaccination programs. We assessed the impact of the qHPV vaccine and Ontario’s grade 8 qHPV vaccination program on cervical dysplasia and anogenital warts (AGW)… Conclusions: This study provides strong evidence of the early benefits of qHPV vaccination among girls aged 14 to 17 years, offering additional justification for not delaying vaccination.

Length of publication: 9-page article

‘I didn’t even know boys could get the vaccine’: Parents’ reasons for human papillomavirus (HPV) vaccination decision making for their sons

Source: Psycho-Oncology, 2015, 10.1002/pon.3894

Follow this link for abstract

Date of publication: July 2015

Publication Type: Journal Article

In a nutshell: Objective: The study’s objective was to examine parents’ reasons for their decision to vaccinate their 9–16-year-old sons with the human papillomavirus (HPV) vaccine. ‘I didn’t even know boys could get the vaccine’: Parents’ reasons for human papillomavirus (HPV) vaccination decision making for their sons… Conclusion: There are important differences in the factors that influence parents’ decision depending on where they are along the decision-making trajectory. Assuring that parents are well informed about the importance of male vaccination, reducing vaccine cost, accurately communicating vaccine safety, and improving patient–provider communication may augment vaccine coverage and prevent HPV-associated cancers

Length of publication: 8-page article